Preventing Peritoneal Adhesion
What do we do at Akesion
Nordmark has acquired majority shares of Akesion - a young private biopharmaceutical company specialized in the development of novel and innovative therapeutics for the treatment of diseases with high unmet medical needs, thereby creating value for patients and investors. The company was founded in 2014 by an experienced management team in order to provide the commercial infrastructure for the founder’s research activities.
Along with Nordmark's expertise the team possesses significant expertise throughout the entire process of drug development and registration. In addition, the company has access to a wide network of specialists and advisors. The company structure ensures assignment of the best available resources to the developing needs of a drug project.
Meet the Management Team
Dr. Jörn Tonne
Dr. Stephan Witte
We look forward to hearing from you!
Data protection notice